找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Regional Therapy; HAI, HIPEC, HILP, IL Yuman Fong,T. Clark Gamblin,Jonathan S. Zager Book 2020 Springer Nature Switzerland AG 2020 L

[復(fù)制鏈接]
查看: 17197|回復(fù): 59
樓主
發(fā)表于 2025-3-21 19:57:06 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Cancer Regional Therapy
副標(biāo)題HAI, HIPEC, HILP, IL
編輯Yuman Fong,T. Clark Gamblin,Jonathan S. Zager
視頻videohttp://file.papertrans.cn/222/221186/221186.mp4
概述Provides a state of the art overview of cancer regional therapy.Authored by the clinicians who have pioneered the field.The definitive text on the theory and practice of CRT
圖書(shū)封面Titlebook: Cancer Regional Therapy; HAI, HIPEC, HILP, IL Yuman Fong,T. Clark Gamblin,Jonathan S. Zager Book 2020 Springer Nature Switzerland AG 2020 L
描述.This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the theory and practice of CRT. It begins with a summary of the history, technical principles that underlie regional therapy. The following parts discuss current data and practice in peritoneal, liver, limb, pleural and other sites. Included in the practice are considerations of workflow and financial issues revolving around CRT. Novel techniques and therapies under investigation are presented to inform the direction of the field. ..?..Cancer Regional Therapy. summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines..
出版日期Book 2020
關(guān)鍵詞Liver Infusional Therapies; Hepatic Arterial Infusional Therapy; Perfusional Therapies; Photodynamic Th
版次1
doihttps://doi.org/10.1007/978-3-030-28891-4
isbn_softcover978-3-030-28893-8
isbn_ebook978-3-030-28891-4
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

書(shū)目名稱(chēng)Cancer Regional Therapy影響因子(影響力)




書(shū)目名稱(chēng)Cancer Regional Therapy影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Cancer Regional Therapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Cancer Regional Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Cancer Regional Therapy被引頻次




書(shū)目名稱(chēng)Cancer Regional Therapy被引頻次學(xué)科排名




書(shū)目名稱(chēng)Cancer Regional Therapy年度引用




書(shū)目名稱(chēng)Cancer Regional Therapy年度引用學(xué)科排名




書(shū)目名稱(chēng)Cancer Regional Therapy讀者反饋




書(shū)目名稱(chēng)Cancer Regional Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:17:35 | 只看該作者
https://doi.org/10.1057/9781137010490stemic circulation either by diffusion into the vascular compartment or by absorption through peritoneal lymphatics. In addition, the peritoneal-plasma barrier allows dose intensification providing high concentrations of the therapeutic agent while minimizing systemic toxicity. Traditionally, the se
板凳
發(fā)表于 2025-3-22 03:35:36 | 只看該作者
地板
發(fā)表于 2025-3-22 04:56:08 | 只看該作者
5#
發(fā)表于 2025-3-22 10:38:09 | 只看該作者
6#
發(fā)表于 2025-3-22 16:16:23 | 只看該作者
7#
發(fā)表于 2025-3-22 19:33:07 | 只看該作者
8#
發(fā)表于 2025-3-23 00:11:19 | 只看該作者
Arthur Benz,Stefan Kuhlmann,Dieter Sadowskin from a urachal primary, is an exceedingly rare disease whose pathophysiologic characteristics have mainly been determined by case series. As there is no standard systemic therapy for urachal carcinomatosis, CRS/HIPEC provides a useful treatment strategy, with a median overall survival approaching
9#
發(fā)表于 2025-3-23 03:34:55 | 只看該作者
https://doi.org/10.1007/978-3-030-46420-2tients with colorectal primaries, major complication rates range from 31% to 47% in patients with HI and 11% to 31% in patients without HI. Thirty-day mortality in patients with HI ranges from 0 to 3%, and 0.6% to 5% in patients without HI. Median OS is 13 to 35.3?months in patients with HI, and fro
10#
發(fā)表于 2025-3-23 09:31:24 | 只看該作者
stigation are presented to inform the direction of the field. ..?..Cancer Regional Therapy. summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines..978-3-030-28893-8978-3-030-28891-4
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 17:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
星子县| 苍溪县| 大田县| 静海县| 繁峙县| 塔城市| 启东市| 禄丰县| 楚雄市| 麻阳| 中山市| 玉树县| 东台市| 铜梁县| 新闻| 淅川县| 武功县| 沁阳市| 澜沧| 余姚市| 张家界市| 普宁市| 鄄城县| 宜良县| 宁陕县| 沛县| 屏南县| 赤水市| 西贡区| 墨玉县| 五常市| 静安区| 兰溪市| 建湖县| 文安县| 山西省| 齐齐哈尔市| 屏南县| 丹东市| 元氏县| 尼勒克县|